Literature DB >> 28249912

Prognostic Evaluation of Neutrophil/Lymphocyte Ratio in Patients with Mycosis Fungoides.

Fatma Pelin Cengiz1, Nazan Emiroglu2, Dilek Biyik Ozkaya2, Anil Gulsel Bahali2, Ozlem Su2, Nahide Onsun2.   

Abstract

BACKGROUND: The role of inflammation has been established in cancer biology and the neutrophil to lymphocyte ratio postulated as a marker of systemic inflammatory response. The prognostic significance of neutrophil to lymphocyte ratio has never been explored in patients with mycosis fungoides.
METHODS: Data from 119 mycosis fungoides (MF) patients, diagnosed between 1998 and 2015 at a single centre, were evaluated retrospectively. The prognostic influence of the neutrophil to lymphocyte ratio and other clinico-pathological factors including age, lactate dehydrogenase, stage of disease, beta-2-microglobulin levels, and total IgE levels were evaluated.
RESULTS: The mean value of absolute neutrophil count and absolute lymphocyte count (ANC/ALC) ratio was 2.07±1.17 in the patient group, whereas it was 1.76±0.53 in the control group (P<0.05). An ANC/ALC value of 2.85 corresponded to the maximum combined sensitivity and specificity on the ROC curve. ANC/ALC ratios of 2.85 or higher at diagnosis were positively correlated with elevated Beta-2-microglobulin (P=0.026), advanced disease stage, and disease progression (P=0.026, r=0.204) (P=0 .006, r=0.251) (P=0 .018, r=0.216).
CONCLUSION: In the present study, we showed that a high ANC/ALC ratio at diagnosis of MF represents a simple, poor prognostic factor for identifying high-risk patients with MF.
© 2017 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Lymphocyte; Mycosis Fungoides; Neutrophil; Prognosis; Ratio

Mesh:

Year:  2017        PMID: 28249912

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  5 in total

Review 1.  Cutaneous T-cell Lymphoma.

Authors:  Melissa Pulitzer
Journal:  Clin Lab Med       Date:  2017-09       Impact factor: 1.935

2.  Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.

Authors:  Jongheon Jung; Hyewon Lee; Tak Yun; Eunyoung Lee; Hae Moon; Jungnam Joo; Weon Seo Park; Mihong Choi; Jeong-Ok Lee; Jong Seok Lee; Hyeon-Seok Eom
Journal:  Oncotarget       Date:  2017-08-24

3.  Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Marc Schwartz; Martina Manni; Vittoria Tarantino; Stefano Pileri; Young-Hyeh Ko; Maria E Cabrera; Steven Horwitz; Won S Kim; Andrei Shustov; Francine M Foss; Arnon Nagler; Kenneth Carson; Lauren C Pinter-Brown; Silvia Montoto; Michele Spina; Tatyana A Feldman; Mary J Lechowicz; Sonali M Smith; Frederick Lansigan; Raul Gabus; Julie M Vose; Ranjana H Advani
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

Review 4.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.

Authors:  Paulina Stefaniuk; Agnieszka Szymczyk; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

5.  Prognostic significance of neutrophil to lymphocyte ratio in ovarian cancer: evidence from 4,910 patients.

Authors:  Quan Zhou; Li Hong; Man-Zhen Zuo; Ze He
Journal:  Oncotarget       Date:  2017-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.